- Filed
- May 14, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 1, 2026 | 29.35M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 23.3M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 16.9M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $521K |
| Capex | Q1 2026 · Mar 31, 2025 | $0 |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$11.66M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$8.62M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $34.11M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $37.91M |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $10.51M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $9.08M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $42.85M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $20.44M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $108.89M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $74.9M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $80.06M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $81.26M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $51.93M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $52.86M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $133.63M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $127.65M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $88.54M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $58.55M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $242.52M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $202.55M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.49 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.63 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.49 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.63 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $9.29M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $7.49M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$11.5M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$10.61M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$8.19M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$5.9M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $40.96M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $35.35M |
| Revenue | Q1 2026 · Mar 31, 2026 | $50.12M |
| Revenue | Q1 2026 · Mar 31, 2025 | $39.31M |